Keyphrases
Lipopolysaccharide
100%
Pseudomonas Aeruginosa (P. aeruginosa)
100%
Interleukin-10 Knockout Mouse
100%
Endotoxin Priming
100%
Wild Mice
42%
Interleukin-10
42%
Interleukin-12 (IL-12)
42%
IL-10 Knockout Mice
42%
Spleen
28%
Interferon-α (IFN-α)
28%
Lipopolysaccharide Tolerance
28%
Systemic Clearance
28%
Lung
14%
Systemic Infection
14%
Anti-inflammatory Cytokines
14%
Cytokine Production
14%
Immunosuppression
14%
Lipopolysaccharide Endotoxin
14%
Lipopolysaccharide-induced
14%
Endotoxin
14%
Interferon-γ
14%
Systemic Challenges
14%
Prior Exposure
14%
Opportunistic Pathogens
14%
IL-10 Production
14%
Lipopolysaccharide Challenge
14%
Altered States
14%
Post-inflammatory
14%
Pharmacology, Toxicology and Pharmaceutical Science
Knockout Mouse
100%
Lipopolysaccharide
100%
Pseudomonas aeruginosa
100%
Endotoxin
100%
Interleukin 10
100%
Wild Type Mouse
27%
Cytokine
27%
Interleukin 12
27%
Interferon
18%
Infectious Agent
9%
Sepsis
9%
Anti-Inflammatory Drug
9%
Gamma Interferon
9%
Immunology and Microbiology
Knockout Mouse
100%
Wild Type
100%
Interleukin 10
100%
Pseudomonas aeruginosa
100%
Wild Type Mouse
37%
Interleukin 12
37%
interferon
25%
Cytokine
12%
Infectious Agent
12%
Secretion (Process)
12%
Inflammatory Cytokine
12%
Cytokine Production
12%
Neutralization
12%
Immunosuppression
12%
Interferon Gamma
12%
Infection
12%